Diploma (LON:DPLM) Lowered to Hold Rating by Shore Capital

Shore Capital downgraded shares of Diploma (LON:DPLMFree Report) to a hold rating in a report issued on Tuesday, Marketbeat.com reports.

Diploma Trading Up 2.4 %

LON:DPLM opened at GBX 4,222 ($53.15) on Tuesday. The stock has a 50-day simple moving average of GBX 4,389.26 and a 200-day simple moving average of GBX 4,265.50. The company has a debt-to-equity ratio of 45.69, a quick ratio of 0.80 and a current ratio of 2.27. The stock has a market cap of £5.66 billion, a P/E ratio of 4,869.77, a P/E/G ratio of 2.82 and a beta of 0.75. Diploma has a 1 year low of GBX 3,200 ($40.29) and a 1 year high of GBX 4,653 ($58.58).

Diploma Increases Dividend

The company also recently disclosed a dividend, which will be paid on Friday, January 31st. Shareholders of record on Thursday, January 16th will be paid a GBX 42 ($0.53) dividend. This is a boost from Diploma’s previous dividend of $17.30. This represents a yield of 0.93%. The ex-dividend date of this dividend is Thursday, January 16th. Diploma’s payout ratio is currently 6,627.91%.

Insiders Place Their Bets

In other Diploma news, insider Johnny Thomson sold 26,794 shares of the stock in a transaction on Tuesday, November 19th. The stock was sold at an average price of GBX 4,536 ($57.11), for a total transaction of £1,215,375.84 ($1,530,121.92). 0.52% of the stock is currently owned by insiders.

About Diploma

(Get Free Report)

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.

Recommended Stories

Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.